(Allergan plc)

	AGN latest price $292.8886 (1.41%) ($288.3909 - $293.9598) on Tue. Jun. 30, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.25% (three month average)
RSI	54
Latest Price	$292.8886(1.41%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.6% a day on average for past five trading days.
Weekly Trend	AGN advances 0.8% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(54%)    IBB(53%)    XBI(47%)    SPY(43%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.625% in a week (0% probabilities).   VIXM(-31%)    TLT(-19%)    SHY(-7%)    UUP(-6%)    IGOV(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.625% (StdDev 1.25%)
Hourly BBV	0 ()
Intraday Trend	0.7%

5 Day Moving Average	$294.78(-0.64%)
10 Day Moving Average	$294.45(-0.53%)
20 Day Moving Average	$292.52(0.13%)
To recent high	-3.1%
To recent low	7.3%
Market Cap	$96.565b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed